+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America and Europe Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report by Product (Volumetric Infusion Pumps, Syringe Infusion Pumps), Disease Indication (Chemotherapy), End-Use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • February 2025
  • Region: Europe, North America
  • Grand View Research
  • ID: 6056011
Description Jump to:
The North America and Europe Intravenous Infusion Pumps Market was valued at USD 4.45 billion in 2024, and is projected to reach USD 7.06 billion by 2030, rising at a CAGR of 8.10%. This growth is attributed to the increase in the prevalence of chronic diseases such as respiratory diseases, stroke, diabetes, cancer, and cardiovascular diseases, wherein cardiovascular disease is the major cause of death in Europe and North America. For instance, according to the U.S. Department of Health and Human Services, an estimated 129 million people in the US have at least one major chronic disease. Intravenous infusion pumps ensure controlled, regulated, & error-free delivery of nutrients and medications while treating patients via radiation therapy or chemotherapy, as these are very complex processes and require precise dosages of medication. The use of these pumps helps in reducing errors during administration, as medication errors are the most common types of errors and cannot be taken carelessly while handling patients with chronic diseases.

There is a need for advanced delivery systems that are safer, more efficient, and standardized. The introduction of smart infusion pumps or next-generation intravenous pumps is imparting greater growth opportunities for the overall pump market. Smart pumps are infusion devices that are embedded with a computer software system aimed at decreasing drug dosing errors through the presence of drug libraries, ensuring safe medication administration. For instance, in April 2024, Mackenzie Health in Canada became the first healthcare system to implement BD Alaris EMR Interoperability, enabling two-way communication between IV infusion pumps and electronic medical records (EMRs). This advancement eliminates the need for manual programming, significantly reducing medication administration errors while improving workflow efficiency. Studies show an 86% reduction in keystrokes needed for infusion programming. Such smart infusion technologies are driving market growth by increasing hospital demand for interoperable and automated IV pumps.

Regulatory approvals of advanced infusion pump technologies are a key market driver for the intravenous infusion pump market, improving patient safety, efficiency, and connectivity in healthcare settings. For instance, in April 2024, Baxter International Inc. recently received FDA 510(k) clearance for its Novum IQ large volume infusion pump with Dose IQ Safety Software, expanding its Novum IQ Infusion Platform. This integrated system, which includes both large volume and syringe pumps, allows clinicians to use a single, connected platform across multiple care settings, enhancing workflow efficiency and reducing medication errors. As hospitals increasingly adopt smart, interoperable infusion technologies, demand for next-generation IV pumps is expected to grow significantly.

North America And Europe Intravenous Infusion Pumps Market Report Segmentation

This report forecasts revenue growth at regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the North America and Europe intravenous infusion pumps market report on the basis of product, disease indication, end-use, and region:

Product Outlook (Revenue, USD Million, 2018-2030)

  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Implantable Infusion Pumps
  • Others

Disease Indication Outlook (Revenue, USD Million, 2018-2030)

  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • Others

End-use Outlook (Revenue, USD Million, 2018-2030)

  • Hospitals
  • Homecare
  • Others

Regional Outlook (Revenue, USD Million, 2018-2030)

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Disease Indication
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Segment
2.2.2. Disease Indication Segment
2.2.3. End-use Segment
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. North America and Europe Intravenous Infusion Pumps Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of chronic diseases
3.2.1.2. Technological advancements in infusion pumps
3.2.1.3. Rising demand for ambulatory infusion pumps
3.2.2. Market restraint analysis
3.2.2.1. Lack of reimbursement
3.2.2.2. Increasing product recalls
3.3. North America and Europe Intravenous Infusion Pumps Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. North America and Europe Intravenous Infusion Pumps Market: Product Estimates & Trend Analysis
4.1. North America and Europe Intravenous Infusion Pumps Market: Product Dashboard
4.2. North America and Europe Intravenous Infusion Pumps Market: Product Movement Analysis
4.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Volumetric Infusion Pumps
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Syringe Infusion Pumps
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Ambulatory Infusion Pumps
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Patient-Controlled Analgesia Infusion Pumps
4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.8. Implantable Infusion Pumps
4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Estimates & Trend Analysis
5.1. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Dashboard
5.2. North America and Europe Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
5.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
5.4. Chemotherapy
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Diabetes
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Gastroenterology
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.7. Analgesia/Pain Management
5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.8. Pediatrics/Neonatology
5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.9. Hematology
5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.10. Others
5.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. North America and Europe Intravenous Infusion Pumps Market: End-use Estimates & Trend Analysis
6.1. North America and Europe Intravenous Infusion Pumps Market: End-use Dashboard
6.2. North America and Europe Intravenous Infusion Pumps Market: End-use Movement Analysis
6.3. North America and Europe Intravenous Infusion Pumps Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Homecare
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. North America and Europe Intravenous Infusion Pumps Market: Regional Estimates & Trend Analysis by Country, Product, Disease Indication, and End-use
7.1. North America and Europe Intravenous Infusion Pumps Market: Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. U.S. market estimates and forecast, 2018-2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Canada market estimates and forecast, 2018-2030 (USD Million)
7.4. Europe
7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. UK market estimates and forecast, 2018-2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. Germany market estimates and forecast, 2018-2030 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. France market estimates and forecast, 2018-2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Italy market estimates and forecast, 2018-2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Spain market estimates and forecast, 2018-2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecast, 2018-2030 (USD Million)
7.4.8. Norway
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Norway market estimates and forecast, 2018-2030 (USD Million)
7.4.9. Denmark
7.4.9.1. Key country dynamics
7.4.9.2. Regulatory framework/ reimbursement structure
7.4.9.3. Competitive scenario
7.4.9.4. Denmark market estimates and forecast, 2018-2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Manufacturers
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2024
8.3.4. Baxter
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. End-use benchmarking
8.3.4.4. Strategic initiatives
8.3.5. B. Braun Melsungen AG
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. End-use benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Fresenius Kabi AG
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. End-use benchmarking
8.3.6.4. Strategic initiatives
8.3.7. ICU Medical, Inc. (Smiths Medical)
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. End-use benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Micrel Medical Devices SA
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. End-use benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Boston Scientific Corporation
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. End-use benchmarking
8.3.9.4. Strategic initiatives
8.3.10. BD
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. End-use benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Terumo Corporation
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. End-use benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. End-use benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Moog Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. End-use benchmarking
8.3.13.4. Strategic initiatives
8.3.14. IRadimed Corporation
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. End-use benchmarking
8.3.14.4. Strategic initiatives
8.3.15. CODAN Companies
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. End-use benchmarking
8.3.15.4. Strategic initiatives
8.3.16. Arcomed
8.3.16.1. Company overview
8.3.16.2. Financial performance
8.3.16.3. End-use benchmarking
8.3.16.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. North America & Europe Intravenous Infusion Pumps Market, by Country, 2018-2030 (USD Million)
Table 4. North America & Europe Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million) (Volume Unit)
Table 5. North America & Europe Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 6. North America & Europe Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 7. North America Intravenous Infusion Pumps Market, by Country, 2018-2030 (USD Million)
Table 8. North America Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 9. North America Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 10. North America Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 11. U.S. Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 12. U.S. Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 13. U.S. Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 14. Canada Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 15. Canada Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 16. Canada Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 17. Mexico Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 18. Mexico Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 19. Mexico Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 20. Europe Intravenous Infusion Pumps Market, by Country, 2018-2030 (USD Million)
Table 21. Europe Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 22. Europe. Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 23. Europe Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 24. Germany Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 25. Germany Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 26. Germany Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 27. UK Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 28. UK Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 29. UK Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 30. France Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 31. France Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 32. France Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 33. Italy Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 34. Italy Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 35. Italy Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 36. Spain Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 37. Spain Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 38. Spain Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 39. Denmark Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 40. Denmark Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 41. Denmark Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 42. Sweden Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 43. Sweden Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 44. Sweden Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 45. Norway Intravenous Infusion Pumps Market, by Product, 2018-2030 (USD Million)
Table 46. Norway Intravenous Infusion Pumps Market, by Disease Indication, 2018-2030 (USD Million)
Table 47. Norway Intravenous Infusion Pumps Market, by End Use, 2018-2030 (USD Million)
Table 48. Participant’s Overview
Table 49. Financial Performance
Table 50. Product Benchmarking
Table 51. Strategic Initiatives
List of Figures
Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Market Formulation & Validation
Figure 5 Intravenous Infusion Pumps Market, Market Segmentation
Figure 6 Market Driver Analysis (Current & Future Impact)
Figure 7 Market Restraint Analysis (Current & Future Impact)
Figure 8 Market Opportunity Analysis (Current & Future Impact)
Figure 9 Market Challenge Analysis (Current & Future Impact)
Figure 10 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
Figure 11 Porter’s Five Forces Analysis
Figure 12 Regional Marketplace: Key Takeaways
Figure 13 North America & Europe Intravenous Infusion Pumps Market, for Ultrasound, 2018-2030 (USD Million)
Figure 14 North America & Europe Intravenous Infusion Pumps Market, for Product, 2018-2030 (USD Million)
Figure 15 North America & Europe Intravenous Infusion Pumps Market, for Volumetric Infusion Pumps, 2018-2030 (USD Million)
Figure 16 North America & Europe Intravenous Infusion Pumps Market, for Syringe Infusion Pumps, 2018-2030 (USD Million)
Figure 17 North America & Europe Intravenous Infusion Pumps Market, for Ambulatory Infusion Pumps, 2018-2030 (USD Million) (Procedure Volume)
Figure 18 North America & Europe Intravenous Infusion Pumps Market, for Patient-Controlled Analgesia Infusion Pumps, 2018-2030 (USD Million)
Figure 19 North America & Europe Intravenous Infusion Pumps Market, for Implantable Infusion Pumps, 2018-2030 (USD Million)
Figure 20 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018-2030 (USD Million)
Figure 21 North America & Europe Intravenous Infusion Pumps Market, for Disease Indication, 2018-2030 (USD Million)
Figure 22 North America & Europe Intravenous Infusion Pumps Market, for Chemotherapy, 2018-2030 (USD Million)
Figure 23 North America & Europe Intravenous Infusion Pumps Market, for Diabetes, 2018-2030 (USD Million)
Figure 24 North America & Europe Intravenous Infusion Pumps Market, for Gastroenterology, 2018-2030 (USD Million)
Figure 25 North America & Europe Intravenous Infusion Pumps Market, for Analgesia/Pain Management, 2018-2030 (USD Million)
Figure 26 North America & Europe Intravenous Infusion Pumps Market, for Pediatrics/Neonatology, 2018-2030 (USD Million)
Figure 27 North America & Europe Intravenous Infusion Pumps Market, for Hematology, 2018-2030 (USD Million)
Figure 28 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018-2030 (USD Million)
Figure 29 North America & Europe Intravenous Infusion Pumps Market, for End Use, 2018-2030 (USD Million)
Figure 30 North America & Europe Intravenous Infusion Pumps Market, for Hospitals, 2018-2030 (USD Million)
Figure 31 North America & Europe Intravenous Infusion Pumps Market, for Homecare, 2018-2030 (USD Million)
Figure 32 North America & Europe Intravenous Infusion Pumps Market, for Others, 2018-2030 (USD Million)
Figure 33 Regional Outlook, 2024 & 2030
Figure 34 North America Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 35 U.S. Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 36 Canada Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 37 Europe Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 38 Germany Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 39 UK Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 40 France Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 41 Italy Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 42 Spain Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 43 Denmark Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 44 Sweden Intravenous Infusion Pumps Market, 2018-2030 (USD Million)
Figure 45 Norway Intravenous Infusion Pumps Market, 2018-2030 (USD Million)

Companies Mentioned

The major companies profiled in this North America and Europe Intravenous Infusion Pumps market report include:
  • Baxter
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • ICU Medical, Inc. (Smiths Medical)
  • Micrel Medical Devices SA
  • Boston Scientific Corporation
  • BD
  • Terumo Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Moog Inc.
  • IRadimed Corporation
  • CODAN Companies
  • Arcomed

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedFebruary 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.06 Billion
Compound Annual Growth Rate8.1%
Regions CoveredEurope, North America
No. of Companies Mentioned13

Related Topics

Related Reports

Intravenous Infusion Pump Market by Product, Disease Indication - Global Forecast 2025-2030 - Product Image

Intravenous Infusion Pump Market by Product, Disease Indication - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Home Infusion Services Market by Product, Indication, Application - Global Forecast 2025-2030 - Product Image

Home Infusion Services Market by Product, Indication, Application - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Intravenous Infusion Pump Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology - Product Image

Intravenous Infusion Pump Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

  • Report
  • 102 Pages
  • Global
From
Global Elastomeric Infusion Pumps Market Outlook 2026 - Product Image

Global Elastomeric Infusion Pumps Market Outlook 2026

  • Report
  • 213 Pages
  • Global
From
Home Infusion Therapy Market Report and Forecast 2024-2032 - Product Image

Home Infusion Therapy Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From

About the Infusion Pump Market

The Infusion Pump market is a subset of the larger Infusions and Injectables market. Infusion pumps are medical devices used to deliver fluids, such as nutrients and medications, into a patient's body in controlled amounts. They are used in a variety of medical settings, including hospitals, clinics, and home care. Infusion pumps are designed to provide precise and accurate delivery of fluids, and are used to treat a wide range of conditions, including diabetes, cancer, and heart failure. Infusion pumps are typically classified into two categories: syringe pumps and volumetric pumps. Syringe pumps are used to deliver small doses of medication, while volumetric pumps are used to deliver larger doses. Both types of pumps are used in a variety of medical settings, including hospitals, clinics, and home care. The Infusion Pump market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include B. Braun, Baxter, Medtronic, Smiths Medical, and Hospira. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.